This document discusses the relationship between pharmacogenomics, genetics, and molecular diagnostic and therapeutic technologies in relation to personalized medicine. It explains that pharmacogenomics studies drug response in relation to an individual's entire gene complement, while pharmacogenetics focuses on a smaller number of genes. The study of these fields is important for personalized medicine due to genetic and environmental factors that influence drug metabolism and response. Molecular diagnostic technologies like next generation sequencing and DNA chips can provide genetic information to guide personalized treatment selection and dosing based on a person's genetic profile. The goal of these approaches is to optimize medical care for each individual.